These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 18262313

  • 21. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E, Hernández González R, Alonso Morales R, Aguilar-Setién A.
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [Abstract] [Full Text] [Related]

  • 22. Protective immunity induced by systemic and mucosal delivery of DNA vaccine expressing glycoprotein B of pseudorabies virus.
    Yoon HA, Han YW, Aleyas AG, George JA, Kim SJ, Kim HK, Song HJ, Cho JG, Eo SK.
    J Microbiol Biotechnol; 2008 Mar; 18(3):591-9. PubMed ID: 18388482
    [Abstract] [Full Text] [Related]

  • 23. Canine adenovirus based rabies vaccines.
    Tordo N, Foumier A, Jallet C, Szelechowski M, Klonjkowski B, Eloit M.
    Dev Biol (Basel); 2008 Mar; 131():467-76. PubMed ID: 18634509
    [Abstract] [Full Text] [Related]

  • 24. Type I IFN modulates the immune response induced by DNA vaccination to pseudorabies virus glycoprotein C.
    Tudor D, Riffault S, Carrat C, Lefèvre F, Bernoin M, Charley B.
    Virology; 2001 Jul 20; 286(1):197-205. PubMed ID: 11448172
    [Abstract] [Full Text] [Related]

  • 25. Evaluation in swine of a subunit vaccine against pseudorabies.
    Maes RK, Schutz JC.
    Am J Vet Res; 1983 Jan 20; 44(1):123-5. PubMed ID: 6297337
    [Abstract] [Full Text] [Related]

  • 26. Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins.
    Dory D, Torché AM, Béven V, Blanchard P, Loizel C, Cariolet R, Jestin A.
    Vaccine; 2005 May 16; 23(26):3483-91. PubMed ID: 15837372
    [Abstract] [Full Text] [Related]

  • 27. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
    Kaur M, Saxena A, Rai A, Bhatnagar R.
    FASEB J; 2010 Jan 16; 24(1):173-83. PubMed ID: 19741168
    [Abstract] [Full Text] [Related]

  • 28. Immunogenicity and protective efficacy induced by an mRNA vaccine encoding gD antigen against pseudorabies virus infection.
    Jiang Z, Zhu L, Cai Y, Yan J, Fan Y, Lv W, Gong S, Yin X, Yang X, Sun X, Xu Z.
    Vet Microbiol; 2020 Dec 16; 251():108886. PubMed ID: 33129042
    [Abstract] [Full Text] [Related]

  • 29. [Safety and efficacy of an antirabies vaccine consisting of recombinant vaccinia-rabies virus administered orally to the fox, dog and cat].
    Blancou J, Artois M, Brochier B, Thomas I, Pastoret PP, Desmettre P, Languet B, Kiény MP.
    Ann Rech Vet; 1989 Dec 16; 20(2):195-204. PubMed ID: 2751231
    [Abstract] [Full Text] [Related]

  • 30. Vaccination of dogs against pseudorabies (Aujeszky's disease), using an inactivated-virus vaccine.
    Pensaert MB, Commeyne S, Andries K.
    Am J Vet Res; 1980 Dec 16; 41(12):2016-9. PubMed ID: 6259977
    [No Abstract] [Full Text] [Related]

  • 31. Development and immunogenicity of a recombinant pseudorabies virus expressing Sj26GST and SjFABP from Schistosoma japonicum.
    Wei F, Zhai Y, Jin H, Shang L, Men J, Lin J, Fu Z, Shi Y, Zhu XQ, Liu Q, Gao H.
    Vaccine; 2010 Jul 19; 28(32):5161-6. PubMed ID: 20561603
    [Abstract] [Full Text] [Related]

  • 32. In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets.
    Linghua Z, Xingshan T, Fengzhen Z.
    Vaccine; 2008 Jan 10; 26(2):224-33. PubMed ID: 18063448
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L, Feng N, Wang X, Ge J, Wen Z, Chen W, Qin L, Xia X, Bu Z.
    Antiviral Res; 2015 Sep 10; 121():9-15. PubMed ID: 26093157
    [Abstract] [Full Text] [Related]

  • 35. DNA priming and killed virus boosting vaccination strategy can augment the immune response to pseudorabies virus.
    Chen ZH, Guo X, Ge XN, Jia H, Yang HC.
    Acta Virol; 2007 Sep 10; 51(3):163-70. PubMed ID: 18076306
    [Abstract] [Full Text] [Related]

  • 36. [Construction and identification of recombinant canine adenovirus type 2 expressing exogenous rabies glycoprotein (Rgp)].
    Zhao ZP, Xia XZ, Hu RL, Xie ZJ, Yan F, Huang G, Yang ST.
    Wei Sheng Wu Xue Bao; 2007 Apr 10; 47(2):335-9. PubMed ID: 17552245
    [Abstract] [Full Text] [Related]

  • 37. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies.
    Tims T, Briggs DJ, Davis RD, Moore SM, Xiang Z, Ertl HC, Fu ZF.
    Vaccine; 2000 Jun 15; 18(25):2804-7. PubMed ID: 10812222
    [Abstract] [Full Text] [Related]

  • 38. Construction of a US7/US8/UL23/US3-deleted recombinant pseudorabies virus and evaluation of its pathogenicity in dogs.
    Yin H, Li Z, Zhang J, Huang J, Kang H, Tian J, Qu L.
    Vet Microbiol; 2020 Jan 15; 240():108543. PubMed ID: 31902487
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Genetic engineering of the pseudorabies virus genome to construct live vaccines.
    Post LE, Thomsen DR, Petrovskis EA, Meyer AL, Berlinski PJ, Wardley RC.
    J Reprod Fertil Suppl; 1990 Jan 15; 41():97-104. PubMed ID: 2170641
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.